| Q45786803 | A Sensitive Serodiagnosis of Hepatitis C Virus (HCV) Infection with Two Non‐Fused Peptides: Comparison of Antibody Responses Detected with a Newly Developed Assay and a Commercial Second‐Generation Test |
| Q43038734 | A young woman with chronic hepatitis |
| Q42985987 | An autoantibody cross-reactive to hepatitis C virus core and a host nuclear antigen |
| Q42985417 | Anti-GOR to screen HCV-RNA-positive blood donors |
| Q70462060 | Anti-neutrophil antibodies in chronic hepatitis and the effect of alpha-interferon therapy |
| Q45780655 | Anti-rat liver microsomal and cytosolic antibodies in hepatitis C virus infection |
| Q42986062 | Antibodies against hepatitis C virus in mixed cryoglobulinemia patients |
| Q45015808 | Antibodies against synthetic oligopeptides deduced from the putative core gene for the diagnosis of hepatitis virus infection |
| Q42985404 | Antibodies to hepatitis C virus in autoimmune liver disease: evidence for geographical heterogeneity |
| Q34936701 | Autoimmunity and viruses |
| Q72898835 | Autoimmunity during alpha-interferon therapy for chronic hepatitis C |
| Q41115162 | Autoimmunity in hepatitis C and D virus infection |
| Q41662981 | Cellular and humoral immune reactions against autoantigens and hepatitis C viral antigens in chronic hepatitis C |
| Q42986166 | Chronic hepatitis C associated with anti-liver/kidney microsome-1 antibody is not a subgroup of autoimmune hepatitis |
| Q30431528 | Chronic hepatitis C: the virus, its discovery and the natural history of the disease |
| Q42978010 | Clinical and serological courses of a newborn with post-transfusion hepatitis C. |
| Q43035333 | Clinical course of acute hepatitis C and changes in HCV markers |
| Q43038687 | Correlation of plasma hepatitis C virus RNA levels with serum alanine aminotransferase in non‐A, non‐B chronic liver disease |
| Q41199724 | Cytochromes P450 and UDP-glucuronosyl-transferases as hepatocellular autoantigens |
| Q45108735 | Detection of HCV RNA in subjects with antibody to hepatitis C virus among the general population of Fukuoka, Japan |
| Q42980909 | Detection of Hepatitis C Virus Antibody in the Absence of Viral RNA in Patients with Autoimmune Hepatitis |
| Q43038615 | Detection of hepatitis C viral RNA in sporadic acute non-A, non-B hepatitis by polymerase chain reaction. Its usefulness for the early diagnosis of seronegative infection |
| Q43048410 | Development of a specific enzyme-linked immunosorbent assay for the hepatitis C virus antibody using clone 14. |
| Q43038795 | Effect of alpha-interferon on hepatitis C virus chronic infection in mixed cryoglobulinemia patients |
| Q79439029 | Effect of early recurrence of hepatitis C on late biliary anastomotic stricture after liver transplantation |
| Q67992094 | False-positive result of hepatitis C enzyme-linked immunosorbent assay in children with autoimmune hepatitis |
| Q39323439 | Fibroblast Subtypes Regulate Responsiveness of Luminal Breast Cancer to Estrogen |
| Q77933533 | Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C |
| Q43049184 | HCV infection and its clinical features in recipients of blood screened for HCV (C100-3) antibody |
| Q43479532 | Hepatitis C virus and autoimmunity: Fortuitous association or reality? |
| Q40857968 | Hepatitis C virus and mixed cryoglobulinaemia |
| Q42983198 | Hepatitis C virus antigen in hepatocytes: immunomorphologic detection and identification |
| Q42983445 | Hepatitis C virus detection is facilitated by the combined use of c100 protein and GOR epitope. |
| Q45731449 | Hepatitis C virus infection and autoimmunity |
| Q45772971 | Hepatitis C virus infection and disease. Diagnostic problems |
| Q27472993 | Hepatitis C virus infection can mimic type 1 (antinuclear antibody positive) autoimmune chronic active hepatitis. |
| Q41225114 | Hepatitis C virus infection: clinical aspects and treatment with interferon alfa |
| Q44484189 | Hepatitis C virus screening and intravenous immunoglobulin safety in Japan |
| Q41669589 | Hepatitis C virus, autoimmunity and rheumatic disease |
| Q45789957 | Hepatitis C virus-related autoimmunity in patients with porphyria cutanea tarda |
| Q42983369 | Immune response to GOR, a marker for non-A, non-B hepatitis and its correlation with hepatitis C virus infection. |
| Q40766556 | Immunobiology and pathogenesis of hepatitis C virus infection |
| Q43038812 | Immunologic and viral markers in the circulation of anti‐HIV negative heroin addicts |
| Q43038838 | Improved detection of antibodies to hepatitis C virus by the second-generation assay in patients with chronic non-A, non-B liver disease |
| Q43036194 | In vitro secretion of anti-GOR protein and anti-hepatitis C virus antibodies in patients with chronic hepatitis C |
| Q42980882 | Induction of Hepatitis C Virus–Specific Humoral and Cellular Immune Responses in Mice and Rhesus by Artificial Multiple Epitopes Sequence |
| Q43036481 | Inverse correlation between the titre of antibody to hepatitis C virus and the degree of hepatitis C viraemia |
| Q34205552 | LKM-1 autoantibodies recognize a short linear sequence in P450IID6, a cytochrome P-450 monooxygenase |
| Q42677971 | Lack of anti-GOR antibody among subjects with GB virus C/hepatitis G virus RNA. |
| Q45872748 | Liver/kidney microsome antibody type 1 and hepatitis C virus infection |
| Q42980063 | Low hepatitis C viremia levels in patients with anti-liver/kidney microsomal antibody type 1 positive chronic hepatitis |
| Q45787028 | Low prevalence of hepatitis C virus infection among hospital staff and acupuncturists in Kyushu, Japan |
| Q43039482 | Low prevalence of hepatitis C virus infection in patients with auto‐immune hepatitis type 1 |
| Q42982623 | Lymphocytic sialadenitis of Sjögren's syndrome associated with chronic hepatitis C virus liver disease |
| Q45886289 | Management of chronic hepatitis C. |
| Q41201723 | Mixed cryoglobulinemia secondary to hepatitis C virus infection |
| Q27473443 | Molecular basis for antibody cross-reactivity between the hepatitis C virus core protein and the host-derived GOR protein |
| Q40524352 | Molecular detection of hepatitis C virus: impact of detection methodology on clinical and laboratory correlations |
| Q35178930 | New Testing Approaches in Transfusion Medicine |
| Q45786554 | Non-muscle myosin as target antigen for human autoantibodies in patients with hepatitis C virus-associated chronic liver diseases |
| Q45777834 | Non-organ specific autoantibodies associated with chronic C virus hepatitis. |
| Q30416187 | Occult infection with hepatitis C virus: friend or foe? |
| Q72313580 | Occurrence of antibody against rat hepatic sinusoidal endothelial cells in sera of patients with autoimmune hepatitis |
| Q42983325 | Overlap and discrepancy between tests for anti-C100, anti-GOR and anti-CP9 in patients with chronic liver disease and inhabitants in Saga, Japan |
| Q41157475 | Pathogenesis of chronic hepatitis C and associated clinical manifestations |
| Q40649145 | Pathogenetic mechanisms of hepatocellular damage in chronic hepatitis C virus infection |
| Q54643006 | Present status of autoimmune hepatitis in Japan |
| Q45747504 | Prevalence and significance of thyroid autoantibodies in patients with chronic hepatitis C virus infection: a prospective controlled study |
| Q43038527 | Prevalence of hepatitis C virus infection among long‐term hemodialysis patients: Detection of hepatitis C virus RNA in plasma |
| Q40432056 | Primary biliary cirrhosis induced by interferon-α therapy for hepatitis C virus infection |
| Q27932925 | Purification of Saccharomyces cerevisiae RNase H(70) and identification of the corresponding gene |
| Q40591268 | Renal manifestations of hepatitis C virus infection |
| Q40432584 | Role of humoral immune responses in hepatitis B and C virus infections. |
| Q42652715 | Sequence analysis of a 37.6 kbp cosmid clone from the right arm of Saccharomyces cerevisiae chromosome XII, carrying YAP3, HOG1, SNR6, tRNA-Arg3 and 23 new open reading frames, among which several homologies to proteins involved in cell division con |
| Q43036035 | Seroepidemiology of hepatitis C virus infection in hemodialysis patients and the general population in Fukuoka and Okinawa, Japan |
| Q45767811 | Serological pattern of hepatitis C virus recurrence after liver transplantation |
| Q36517557 | Serological reactivity and viral genotypes in hepatitis C virus infection. |
| Q27484587 | Serum Immunoglobulin G Antibodies to the GOR Autoepitope Are Present in Patients with Occult Hepatitis C Virus (HCV) Infection despite Lack of HCV-Specific Antibodies |
| Q43038620 | Significance of antibody to the host cellular gene derived epitope GOR in chronic hepatitis C virus infection |
| Q73530395 | Specific liver autoreactivity in schistosomiasis mansoni |
| Q27480578 | The GOR gene product cannot cross-react with hepatitis C virus in humans |
| Q43039248 | The clinical significance of reactivity to individual epitopes of the hepatitis C viral genome |
| Q27481239 | The clinical virology of hepatitis C virus |
| Q40951349 | The humoral immune response in acute and chronic hepatitis B virus infection |
| Q70588149 | The intraportal lymphoid nodule and its environment in chronic active hepatitis C: an immunohistochemical study |
| Q58324429 | The presence of rheumatoid factor in sera from anti-HCV positive blood donors interferes with the detection of HCV-specific IgM |
| Q42654952 | The sequence of a 8 kb segment on the right arm of yeast chromosome VII identifies four new open reading frames and the genes for yTAFII145. |
| Q34375675 | Viral markers in the treatment of hepatitis B and C |
| Q34059192 | Virus, liver and autoimmunity. |
| Q40754969 | Viruses and auto-immune hepatitis |
| Q78658421 | [Interferon-alpha and auto-immunity] |